52 related articles for article (PubMed ID: 1317750)
21. A soluble form of K-sam/FGFR2 protein in the culture medium of human gastric cancer cells.
Kishi T; Yoshida T; Terada M
Biochem Biophys Res Commun; 1994 Aug; 202(3):1387-94. PubMed ID: 8060318
[TBL] [Abstract][Full Text] [Related]
22. Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells.
Lehtola L; Partanen J; Sistonen L; Korhonen J; Wärri A; Härkönen P; Clarke R; Alitalo K
Int J Cancer; 1992 Feb; 50(4):598-603. PubMed ID: 1311287
[TBL] [Abstract][Full Text] [Related]
23. Novel exons located more than 200 kb downstream of the previously described 3' exon of the K-sam gene for generating activated forms of KGF receptor.
Ueda T; Sasaki H; Aoyagi K; Narikiyo M; Tsubosa Y; Kuwahara Y; Sakamoto H; Mafune K; Yoshida T; Makuuchi M; Terada M
Biochem Biophys Res Commun; 1999 Nov; 265(3):739-45. PubMed ID: 10600490
[TBL] [Abstract][Full Text] [Related]
24. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes.
Hattori Y; Odagiri H; Nakatani H; Miyagawa K; Naito K; Sakamoto H; Katoh O; Yoshida T; Sugimura T; Terada M
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5983-7. PubMed ID: 2377625
[TBL] [Abstract][Full Text] [Related]
25. Two cDNAs encoding novel human FGF receptor.
Seno M; Sasada R; Watanabe T; Ishimaru K; Igarashi K
Biochim Biophys Acta; 1991 Jun; 1089(2):244-6. PubMed ID: 1647213
[TBL] [Abstract][Full Text] [Related]
26. Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG).
Ruta M; Burgess W; Givol D; Epstein J; Neiger N; Kaplow J; Crumley G; Dionne C; Jaye M; Schlessinger J
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8722-6. PubMed ID: 2554327
[TBL] [Abstract][Full Text] [Related]
27. Novel human FGF receptors with distinct expression patterns.
Korhonen J; Partanen J; Eerola E; Vainikka S; Ilvesmäki V; Voutilainen R; Julkunen M; Mäkelä T; Alitalo K
Ann N Y Acad Sci; 1991; 638():403-5. PubMed ID: 1664691
[No Abstract] [Full Text] [Related]
28. A cDNA clone overexpressed and amplified in a mouse teratocarcinoma line.
Niwa O; Kumazaki T; Tsukiyama T; Soma G; Miyajima N; Yokoro K
Nucleic Acids Res; 1990 Nov; 18(22):6709. PubMed ID: 2251142
[No Abstract] [Full Text] [Related]
29. Oncoprotein fos activation in epithelial-cells induces an epitheliomesenchymal conversion and changes the receptor encoded by the fgfr-2 messenger-RNA from k-sam to bek.
Scotet E; Reichmann E; Breathnach R; Houssaint E
Oncol Rep; 1995 Mar; 2(2):203-7. PubMed ID: 21597713
[TBL] [Abstract][Full Text] [Related]
30. MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling.
Ren J; Raina D; Chen W; Li G; Huang L; Kufe D
Mol Cancer Res; 2006 Nov; 4(11):873-83. PubMed ID: 17114345
[TBL] [Abstract][Full Text] [Related]
31. Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activity.
Sato N; Hattori Y; Wenlin D; Yamada T; Kamata T; Kakimoto T; Okamoto S; Kawamura C; Kizaki M; Shimada N; Ote Y; Hata J; Ikeda Y
Jpn J Cancer Res; 2002 Apr; 93(4):459-66. PubMed ID: 11985797
[TBL] [Abstract][Full Text] [Related]
32. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
[TBL] [Abstract][Full Text] [Related]
33. Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation.
Hart KC; Robertson SC; Donoghue DJ
Mol Biol Cell; 2001 Apr; 12(4):931-42. PubMed ID: 11294897
[TBL] [Abstract][Full Text] [Related]
34. Molecular and cellular features of esophageal cancer cells.
Nishihira T; Hashimoto Y; Katayama M; Mori S; Kuroki T
J Cancer Res Clin Oncol; 1993; 119(8):441-9. PubMed ID: 8509434
[TBL] [Abstract][Full Text] [Related]
35. A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation.
Ishii H; Yoshida T; Oh H; Yoshida S; Terada M
Mol Cell Biol; 1995 Jul; 15(7):3664-71. PubMed ID: 7791773
[TBL] [Abstract][Full Text] [Related]
36. Detection of T cells responsive to a vascular growth factor in rheumatoid arthritis.
Byrd VM; Zhao XM; Miller GG; Thomas JW
Immunol Res; 1994; 13(2-3):139-44. PubMed ID: 7539824
[TBL] [Abstract][Full Text] [Related]
37. New nucleotide sequence data on the EMBL File Server.
Nucleic Acids Res; 1992 Nov; 20(22):6119-40. PubMed ID: 1461752
[No Abstract] [Full Text] [Related]
38. K-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors.
Hattori Y; Odagiri H; Katoh O; Sakamoto H; Morita T; Shimotohno K; Tobinai K; Sugimura T; Terada M
Cancer Res; 1992 Jun; 52(12):3367-71. PubMed ID: 1317750
[TBL] [Abstract][Full Text] [Related]
39. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines.
Ishii H; Hattori Y; Itoh H; Kishi T; Yoshida T; Sakamoto H; Oh H; Yoshida S; Sugimura T; Terada M
Cancer Res; 1994 Jan; 54(2):518-22. PubMed ID: 8275490
[TBL] [Abstract][Full Text] [Related]
40. Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity.
Itoh H; Hattori Y; Sakamoto H; Ishii H; Kishi T; Sasaki H; Yoshida T; Koono M; Sugimura T; Terada M
Cancer Res; 1994 Jun; 54(12):3237-41. PubMed ID: 8205545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
